Cite
Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report.
MLA
Meyer zu Schwabedissen, Henriette E., et al. “Creatine Kinase Elevation Caused by a Combination of Fluvastatin and Telmisartan in a Patient Heterozygous for the CYP2C9*3 and ABCC2 -24C > T Variants: A Case Report.” BMC Research Notes, vol. 7, no. 1, July 2014, pp. 688–93. EBSCOhost, https://doi.org/10.1186/1756-0500-7-688.
APA
Meyer zu Schwabedissen, H. E., Siegmund, W., Kroemer, H. K., & Rollnik, J. D. (2014). Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report. BMC Research Notes, 7(1), 688–693. https://doi.org/10.1186/1756-0500-7-688
Chicago
Meyer zu Schwabedissen, Henriette E., Werner Siegmund, Heyo K. Kroemer, and Jens D. Rollnik. 2014. “Creatine Kinase Elevation Caused by a Combination of Fluvastatin and Telmisartan in a Patient Heterozygous for the CYP2C9*3 and ABCC2 -24C > T Variants: A Case Report.” BMC Research Notes 7 (1): 688–93. doi:10.1186/1756-0500-7-688.